Cardiotoxicities are associated with immune checkpoint inhibitor (ICI) therapy. Recent case series and retrospective studies have shown that cardiac immune‐related adverse events (irAEs) are rare but potentially fatal complications of immunotherapy, with various underlying risk factors such as combinations of different ICIs. High mortality rates and overreactive inflammation have been observed with ICI‐associated cardiotoxicities, highlighting the necessity of baseline and serial evaluations and the identification and management of cardiac irAEs as early as possible. The clinical presentations of irAEs range from asymptomatic cardiac biomarker elevation, myocarditis and pericardial diseases to heart failure and mild to fatal arrhythmia. Troponin measurement and electrocardiogram are sensitive initial tests, whereas cardiac magnetic resonance imaging and endomyocardial biopsy are both gold standard components of the diagnostic criteria. Close monitoring and timely consultation with a cardiologist are important for the diagnosis of ICI‐related cardiotoxicities, with decisions of stopping or rechallenging ICIs and strategies to manage heart injuries. Treatment principles are made according to risk stratifications. The first‐line medication is glucocorticoids of various doses, and the second‐line immunosuppression includes intravenous immunoglobin, antithymocyte globulin and other immunosuppressants, which are recommended in life‐threatening cases or in cases of resistance/no response to steroids.
The water flooding characteristic curve method is one of the essential techniques to predict recoverable reserves. However, the recoverable reserves indicated by the existing water flooding characteristic curves of low-amplitude reservoirs with strong bottom water increase gradually, and the current local recovery degree of some areas has exceeded the predicted recovery rate. The applicability of the existing water flooding characteristic curves in low-amplitude reservoirs with strong bottom water is lacking, which affects the accurate prediction of development performance. By analyzing the derivation process of the conventional water flooding characteristic curve method, this manuscript finds out the reasons for the poor applicability of the existing water flooding characteristic curve in low-amplitude reservoir with strong bottom water and corrects the existing water flooding characteristic curve according to the actual situation of the oilfield and obtains the improvement method of water flooding characteristic curve in low-amplitude reservoir with strong bottom water. After correction, the correlation coefficient between $$\frac{{k_{ro} }}{{k_{rw} }}$$ and $$S_{w}$$ is 95.92%. According to the comparison between the actual data and the calculated data, in 2021/3, the actual water cut is 97.29%, the water cut predicted by the formula is 97.27%, the actual cumulative oil production is 31.19 × 104t, and the predicted cumulative oil production is 31.31 × 104t. The predicted value is consistent with the actual value. It provides a more reliable method for predicting low-amplitude reservoirs' recoverable ability with strong bottom water and guides the oilfield's subsequent decision-making.
Background: Initiating ivabradine in acute heart failure (HF) is still controversial.Hypothesis: Ivabradine might be effective to be added in acute but hemodynamically stable HF.Methods: A retrospective cohort of hemodynamically stable acute HF patients was enrolled from January 2018 to January 2020 and followed until July 2020. The primary endpoints were all‐cause mortality and rehospitalization for HF. Secondary endpoints included heart rate (HR), cardiac function measured by New York Heart Association (NYHA) class, and left ventricular ejection fraction (LVEF) and adverse events, which were compared between patients with or without ivabradine.Results: A total of 126 patients were enrolled (50 males, median age 54 years, 81% with decompensated HF, median follow‐up of 9 months). In patients treated with ivabradine, although baseline HRs were higher than the reference group (96 vs. 80 bpm), they were comparable after 3 months; more patients tolerated high doses of β‐blockers (27% vs. 7.9%), improved to NYHA class I function (55.6% vs. 23.8%) and exhibited normal LVEFs (37.8% vs. 14.3%) than the reference group (all p < .05). Ivabradine was associated with a significant reduction of rehospitalization for HF than the reference group (25.4% vs.61.9%), with longer event‐free survival times (hazard ratio: 0.45, 95% confidence interval [CI]: 0.25–0.79), and was related with primary endpoints negatively (hazard ratio 0.51, 95% CI: 0.28–0.91) (all p < .05).Conclusion: In patients with acute but hemodynamically stable HF, ivabradine may significantly reduce HR, improve cardiac function, and reduce HF rehospitalization.
The present study aimed to evaluate the reproducibility and accuracy of the optimized algorithm of shear‑wave elastography (SWE) in diagnosing solid thyroid nodules. Two hundred and sixty‑three solid thyroid nodules in 248 patients who underwent conventional ultrasound and SWE, respectively, by two operators were scheduled for fine‑needle aspiration or surgery. Elasticity indices of the mean, minimum and maximum of nodules (EI) and thyroid parenchyma (EInorm) were measured respectively in the same frame of elastographic images for three times by both operators. The intraobserver and interobserver reproducibility of the optimized algorithm were assessed by intraclass correlation coefficients (ICC). Diagnostic performance of the optimized algorithm was compared with that of conventional SWE measurements by receiver‑operating characteristic (ROC) curves. Among a total of 243 nodules included, 121 were benign nodules and 122 were papillary thyroid carcinoma (PTC). Intraobserver reliability for EId and EIr was nearly perfect (ICC>0.80). Interobserver agreement for MEANd, MAXd, MEANr and MAXr was nearly perfect (ICC>0.80). MAXd had the largest areas under the ROC curve which was 0.82. Compared with conventional SWE, the optimized algorithm of SWE shows better reproducibility and performance in diagnosing solid thyroid nodules.
Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive form of peripheral T-cell lymphoma (PTCL). It can present with signs and symptoms that have broad differentials, including fevers, night sweats, and skin rashes. In this case report, we present an interesting case of a young male of Nigerian descent with recently treated malaria who presented with such symptoms and a picture that was complicated, due to an inconclusive excisional biopsy for lymphoma. He was later diagnosed with AITL. Given the patient’s recent exposure to malaria, we will discuss the potential role malaria has in the development of AITL.